Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 76 AL 90

The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease

Cook EK, Sell GL, Schaffer TB, Margolis SS.

Expert Opin Ther Targets. 2019 Apr;23(4):263-265. doi: 10.1080/14728222.2019.1586884. Epub 2019 Mar 5.

Panax ginseng components and the pathogenesis of Alzheimer's disease (Review)

Razgonova MP, Veselov VV, Zakharenko AM, Golokhvast KS, Nosyrev AE, Cravotto G, Tsatsakis A, Spandidos DA.

Mol Med Rep. 2019 Apr;19(4):2975-2998. doi: 10.3892/mmr.2019.9972. Epub 2019 Feb 19.

Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry

Zhang X, Zhang S, Yang Y, Wang D, Gao H.

Phytochemistry. 2019 May;161:41-74. doi: 10.1016/j.phytochem.2019.01.017. Epub 2019 Feb 26.

Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, Kuca K, Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):772-800. doi: 10.2174/1567205016666190228122956.

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, et al.

Nat Genet. 2019 Mar;51(3):414-430. doi: 10.1038/s41588-019-0358-2. Epub 2019 Feb 28.

Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events

Wiciński M, Socha M, Malinowski B, Wódkiewicz E, Walczak M, Górski K, Słupski M, Pawlak-Osińska K.

Int J Mol Sci. 2019 Feb 28;20(5):1050. doi: 10.3390/ijms20051050.

Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far

Bazzari FH, Abdallah DM, El-Abhar HS.

Curr Alzheimer Res. 2019;16(3):261-277. doi: 10.2174/1567205016666190301111120.

A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment

Das B, Yan R.

CNS Drugs. 2019 Mar;33(3):251-263. doi: 10.1007/s40263-019-00613-7.

Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease

Ganeshpurkar A, Swetha R, Kumar D, Gangaram GP, Singh R, Gutti G, Jana S, Kumar D, Kumar A, Singh SK.

Curr Top Med Chem. 2019;19(7):501-533. doi: 10.2174/1568026619666190304153353.

Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease

Day SM, Ma T.

Neurosci Bull. 2019 Oct;35(5):934-936. doi: 10.1007/s12264-019-00355-y. Epub 2019 Mar 7.

The impact of curcumin and its modified formulations on Alzheimer's disease

Farkhondeh T, Samarghandian S, Pourbagher-Shahri AM, Sedaghat M.

J Cell Physiol. 2019 Aug;234(10):16953-16965. doi: 10.1002/jcp.28411. Epub 2019 Mar 7.

Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease

Huang YM, Shen J, Zhao HL.

J Am Geriatr Soc. 2019 Apr;67(4):841-844. doi: 10.1111/jgs.15830. Epub 2019 Mar 9.

Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases

Mendsaikhan A, Tooyama I, Walker DG.

Cells. 2019 Mar 11;8(3):230. doi: 10.3390/cells8030230.

Development of tau-directed small molecule modulators for Alzheimer's disease: a recent patent review (2014-2018)

Lee HE, Lim D, Lee JY, Lim SM, Pae AN.

Pharm Pat Anal. 2019 Jan;8(1):15-39. doi: 10.4155/ppa-2019-0003. Epub 2019 Mar 14.

Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease

Wang T, Liu XH, Guan J, Ge S, Wu MB, Lin JP, Yang LR.

Eur J Med Chem. 2019 May 1;169:200-223. doi: 10.1016/j.ejmech.2019.02.076. Epub 2019 Mar 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias